AMD在Absci投资20M美元,以加强人工智能药物的发现,进入生命科学市场。 AMD invests $20M in Absci to enhance AI drug discovery, entering the life sciences market.

Absci公司是一家AI药品制造公司,与AMD合作,向Absci投资2 000万美元。 Absci Corporation, an AI drug creation company, has teamed up with AMD, which invested $20 million into Absci. 这一伙伴关系将利用AMD的技术加强Absci的AI药物发现工作,尤其是在抗体设计方面。 This partnership will use AMD's technology to enhance Absci's AI drug discovery efforts, particularly in antibody design. 合作的目的是改进生物建模、降低成本和加速创新,标志着AMD以其人工智能芯片进入生命科学市场。 The collaboration aims to improve biological modeling, cut costs, and speed up innovation, marking AMD's entry into the life sciences market with its AI chips.